Navigation Links
PhRMA Applauds House Committee on Foreign Affairs Commitment to Continuing Efforts to Fight AIDS, Tuberculosis, and Malaria Epidemics
Date:2/29/2008

WASHINGTON, Feb. 28 /PRNewswire-USNewswire/ -- Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO Billy Tauzin today released the following statement on the passage of the Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis and Malaria Reauthorization Act (H.R. 5501) by the United States House Committee on Foreign Affairs:

"America's pharmaceutical research companies commend the House Committee on Foreign Affairs for passing the Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis and Malaria Reauthorization Act (H.R. 5501). This admirable bipartisan bill will allow for the continuation of the unprecedented programs and partnerships implemented by the President's Emergency Plan for AIDS Relief (PEPFAR), the President's Malaria Initiative (PMI) and other global health programs.

"We are committed to fighting the global HIV, TB and malaria epidemics and we look forward to continuing to work with the partnerships created by PEPFAR and PMI to find new, innovative solutions to fight these diseases.

"The reauthorization of these initiatives is a groundbreaking step in worldwide efforts. Already, PEPFAR has provided care or treatment for over 6.6 million people infected or affected by HIV/AIDS, including 2.7 million orphans and vulnerable children.

"This bill provides much needed resources to halt the 6,000 new HIV infections that occur every day and the approximately 6 million deaths from HIV, TB and malaria that occur every year, primarily in Africa.

"This bill and the promise it holds for curbing the AIDS, TB and malaria epidemics is a great tribute to the inspirational leadership of the late former chairmen of the Committee, Rep. Tom Lantos and Rep. Henry J. Hyde."

The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country's leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives. PhRMA companies are leading the way in the search for new cures. PhRMA members alone invested an estimated $43 billion in 2006 in discovering and developing new medicines. Industry-wide research and investment reached a record $55.2 billion in 2006.

PhRMA Internet Address: http://www.phrma.org

For information on stories of hope and survival, visit: http://sharingmiracles.com/

For information on how innovative medicines save lives, visit: http://www.innovation.org

For information on the Partnership for Prescription Assistance, visit: http://www.pparx.org

For information on the danger of imported drugs, visit: http://www.buysafedrugs.info


'/>"/>
SOURCE Pharmaceutical Research and Manufacturers of America(PhRMA)
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. PhRMA Celebrates 20th Anniversary of Discoverers Award
2. PhRMA Statement on Enactment of FDA Legislation
3. AGA Institute applauds delay of Aetna sedation restrictions
4. TFAH Applauds Release of CDCs State-Specific Public Health Emergency Preparedness Report
5. OrthoSynetics(TM) Applauds SEC Suit Against Former Company Management
6. Psoriasis Cure Now Applauds Record Government Psoriasis Research Funding
7. PCMA Applauds Secretary Leavitts Support for Requiring E-Prescribing in Medicare
8. Training Magazine Applauds Aflacs Employee Learning Programs
9. MedeFile Applauds U.S. Presidential Hopefuls for Advocating Widespread Adoption of Electronic Medical Records
10. Blunt Applauds Passage of Republican-Crafted SCHIP Extension
11. IOF applauds NOS on NICE Guidance appeal success and urges continued efforts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... 26, 2016 , ... Power Systems, a leading developer and ... Certification Course in Stoughton, Massachusetts. The course was led by Power Systems’ Education ... hour interactive course to qualify participants as certified PowerWave trainers. , PowerWave ...
(Date:5/26/2016)... Grants Pass, OR (PRWEB) , ... May 26, 2016 , ... ... founder of Bio-Logic Aqua® Research Water Life Science® and international water advocate, was honored ... descendant of the women in ancient Egypt who knelt on the banks of the ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... organization to provide strategic sales leadership and to further develop their rapidly expanding ... B.S. in Business Administration with a concentration in Marketing and an M.B.A. with ...
(Date:5/26/2016)... ... May 26, 2016 , ... May 2016 – Lips may be ... popular cosmetic improvement efforts. Record numbers of clients now ask about lip plumping and ... says Kally Papantoniou, MD, of Advanced Dermatology P.C. , The trend is ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... practices, is seeking nominations to serve on its Accreditation and Standards Committees ... , “RadSite’s quality-benchmarking activities incorporate key process and outcome measures, with the ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... LONDON , May 24, 2016 ... erfüllt beide primären Endpunkte ... und Überlegenheit in ‚ausgezeichneter plus guter ... aufsteigenden Colons    ,      (Logo: ... B.V. gab heute neue positive Daten von der ...
(Date:5/24/2016)... -- NxStage Medical, Inc. (Nasdaq: NXTM ), a ... today announced that Jeffrey H. Burbank , Chief ... of investor conferences. Where applicable, a webcast of the ...   ... Friday, June 10, 2016 1:30 p.m. ET ...
(Date:5/24/2016)... HONG KONG , May 24, 2016 /PRNewswire/ ... primer stent de doble terapia del mundo, introduce ... fístula arteriovenosa. OrbusNeich, una compañía global ... cambian las vidas, ha expandido su cartera incluyendo ... catéteres balón JADE™ y Scoreflex™ PTA son los ...
Breaking Medicine Technology: